Cargando…
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044007/ https://www.ncbi.nlm.nih.gov/pubmed/32100488 http://dx.doi.org/10.3802/jgo.2020.31.e43 |
| _version_ | 1783501489661018112 |
|---|---|
| author | Zhang, Ning Wang, Hanjie Yang, Jili |
| author_facet | Zhang, Ning Wang, Hanjie Yang, Jili |
| author_sort | Zhang, Ning |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7044007 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70440072020-03-06 Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 Zhang, Ning Wang, Hanjie Yang, Jili J Gynecol Oncol Correspondence Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020-01-02 /pmc/articles/PMC7044007/ /pubmed/32100488 http://dx.doi.org/10.3802/jgo.2020.31.e43 Text en Copyright © 2020. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Zhang, Ning Wang, Hanjie Yang, Jili Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title | Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title_full | Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title_fullStr | Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title_full_unstemmed | Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title_short | Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| title_sort | comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044007/ https://www.ncbi.nlm.nih.gov/pubmed/32100488 http://dx.doi.org/10.3802/jgo.2020.31.e43 |
| work_keys_str_mv | AT zhangning commentsonaphase12adoseescalationsafetyandpreliminaryefficacystudyoforaltherapeuticvaccineinsubjectswithcervicalintraepithelialneoplasia3 AT wanghanjie commentsonaphase12adoseescalationsafetyandpreliminaryefficacystudyoforaltherapeuticvaccineinsubjectswithcervicalintraepithelialneoplasia3 AT yangjili commentsonaphase12adoseescalationsafetyandpreliminaryefficacystudyoforaltherapeuticvaccineinsubjectswithcervicalintraepithelialneoplasia3 |